← All trials
NCT04396340
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 11, 2020
- Primary completion
- Mar 15, 2021
- Completion date
- Dec 31, 2021
- First posted
- May 20, 2020
- Last posted
- May 22, 2020
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Mersana TherapeuticsLead sponsor
- Mersana TherapeuticsStudy director
- IQVIACollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.